
Equity Accounts for ¥1.39 Trillion of the Deal Value
Mitsui Chemicals' filing breaks down the ¥1.84 trillion acquisition price into ¥1.3921 trillion in equity value and ¥447.9 billion in interest-bearing debt and other items. DBJ's planned ¥200 billion investment is included in the equity component. The final consideration will be determined after adjustments at closing. The agreement would bring JSR under Mitsui Chemicals' control following its acquisition by state-backed Japan Investment Corporation in 2024. At the time of that earlier deal, Japan Investment Corporation said it intended to use JSR to promote consolidation in the semiconductor materials sector.
Bridge Loan and DBJ Investment Anchor the Financing Plan
Mitsui Chemicals plans to finance the transaction initially with a ¥1.64 trillion bridge loan from its principal financial institutions and the ¥200 billion investment from DBJ. Mitsui has also filed to issue up to ¥150 billion in common shares and expects to use the proceeds to repay part of the bridge loan. Its broader financing plan includes bank borrowing, debt issuance and mezzanine financing. DBJ said it would make its investment through a program intended to strengthen supply chains and support a stable supply of critical materials, including semiconductor components and materials.


JSR Adds Photoresists and Other Wafer Processing Materials
JSR's semiconductor materials portfolio includes photoresists for argon fluoride and extreme ultraviolet lithography, as well as multilayer materials, polishing slurries and deposition precursors. Photoresists enable circuit patterns to be transferred onto semiconductor wafers. Chemical mechanical planarization slurries serve a separate function by helping flatten wafer surfaces during fabrication. The acquisition would bring these materials into Mitsui's portfolio alongside products such as pellicles, which protect photomasks from particles, and wafer-processing tapes. Mitsui says the combined range would allow it to serve customers across more stages of chip manufacturing, from wafer fabrication through advanced packaging and assembly.
Mitsui Targets ¥40 Billion in Additional Annual Profit by FY2035
Mitsui Chemicals plans to make JSR a core part of its ICT Solutions business and direct investment toward research, personnel and production facilities. Management is targeting ¥40 billion in additional annual profit by fiscal 2035 through sales growth and cost efficiencies. Its plan calls for offering a broader range of materials to existing customers and combining technical capabilities to develop new products. Mitsui expects existing products and cost savings to contribute earlier, with new products playing a greater role over time. The profit figure is a management target tied to the proposed integration.


Competition and Foreign Investment Reviews Will Shape the Closing Timeline
Mitsui Chemicals is targeting the second half of the fiscal year ending March 2028, corresponding to October 2027 through March 2028. Completion depends on satisfying closing conditions, including the required procedures under competition and foreign investment rules in Japan and overseas. The company said the timing of those reviews will determine the specific closing date. Mitsui expects the effect on its financial results for the fiscal year ending March 2027 to be minor and said it would provide an update if the timetable changes or a more specific closing date becomes available.

